REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,759.00
Bid: 1,759.00
Ask: 1,759.50
Change: 25.50 (1.47%)
Spread: 0.50 (0.028%)
Open: 1,736.00
High: 1,767.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: FTSE 100 treads water at eight-month high

Tue, 21st Jan 2014 16:38

- FTSE 100 fails to break 2013 intraday high- Credit squeeze eases in China- IMF lifts global growth forecaststechMARK 2,846.40 -0.25%FTSE 100 6,834.26 -0.04%FTSE 250 16,144.20 -0.51%After a choppy session, UK markets finished broadly flat on Tuesday as the FTSE 100 teetered at levels not reached in eight months.An easing of credit conditions in China and upwards revisions to growth estimates by the International Monetary Fund (IMF) failed to keep the Footsie in positive territory today, as cautiousness set in after a 3.5% rise over the past month.Despite US markets reopening after a three-day weekend - Wall Street was closed for Martin Luther King Jr. Day yesterday - it was another lacklustre session in London with trading rangebound for most of the day. The benchmark FTSE 100 finished at 6,834.26, down just 2.47 points, erasing gains late on after coming close to last year's intraday high of 6,875 in afternoon trade. Yesterday, the index hit 6,836.72, its best closing level since reaching 6,840.27 in May 2013.Toby Morris, Senior Sales Trader at CMC Markets, said that the 6,875 intraday high reached last year is "the only historical resistance to break before taking on all-time high recorded back in 1999".Stocks rose initially this morning, tracking gains for Asian markets overnight on the back of an easing of credit conditions in China as the central bank injected fresh liquidity into the country's large banks to meet demand for cash ahead of Chinese New Year later this month.Meanwhile, the IMF lifted its growth forecast for the global economy to 3.7% for 2014, up from its previous estimate of 3.6%, owing to upwards revisions to forecasts in the UK, US, Europe and Japan.On a negative note, there was a surprise fall in the German ZEW index on economic sentiment which fell from 62 to 61.7 in January, worse than rise to 64 expected by analysts. The current situation index, however, jumped from 32.4 to 41.2.Intertek jumps on SGS readacross, Unilever gainsIntertek, a provider of testing and safety solutions, jumped as a result of readacross from its sector peer, Swiss firm SGS, which posted upbeat full-year results. Consumer products group Unilever was also high riser today after reporting underlying sales growth of 4.3% for 2013, helped by strong growth in the emerging markets.Drugs maker GlaxoSmithKline rose after reporting that its new HIV treatment, Tivicay, has received approval in Europe. Mining stocks sank on weak metal prices, pushing Randgold Resources, Anglo American, Rio Tinto, Fresnillo, BHP Billiton, and Glencore Xstrata all firmly lower. Investors were also focusing on comments from Goldman Sachs, which adjusted its commodity price forecasts for 2014 and beyond. William Hill and Ladbrokes slumped after JPMorgan Cazenove expressed concerns about potential regulatory restrictions on machine gaming, which could result in "material downgrades and significant shop closures" at the bookmakers. Weir Group slumped after fellow oil services provider Baker Hughes highlighted higher costs for the sector in its fourth-quarter results. Baker said a surplus of natural-gas supply led to lower prices and pushed energy companies to shift operations to oil-rich shale, which is more difficult to tap. British Land was named as HSBC's key 'overweight'-rated company, giving the stock a lift today, as the bank gave an upbeat outlook for UK property sector.FTSE 100 - RisersAssociated British Foods (ABF) 2,806.00p +4.23%Intertek Group (ITRK) 3,000.00p +3.16%Hargreaves Lansdown (HL.) 1,549.00p +2.65%Imperial Tobacco Group (IMT) 2,284.00p +2.51%Standard Chartered (STAN) 1,358.00p +2.26%easyJet (EZJ) 1,710.00p +2.21%Coca-Cola HBC AG (CDI) (CCH) 1,768.00p +2.20%Diageo (DGE) 1,985.00p +1.95%Unilever (ULVR) 2,480.00p +1.76%Babcock International Group (BAB) 1,426.00p +1.71%FTSE 100 - FallersRio Tinto (RIO) 3,231.50p -3.13%Antofagasta (ANTO) 819.50p -3.02%Anglo American (AAL) 1,356.00p -2.66%Weir Group (WEIR) 2,174.00p -2.38%Aberdeen Asset Management (ADN) 426.00p -2.16%Morrison (Wm) Supermarkets (MRW) 250.10p -1.88%William Hill (WMH) 355.40p -1.82%Randgold Resources Ltd. (RRS) 4,112.00p -1.74%BHP Billiton (BLT) 1,854.50p -1.70%BAE Systems (BA.) 437.50p -1.49%FTSE 250 - RisersRank Group (RNK) 150.00p +3.88%African Barrick Gold (ABG) 206.50p +2.94%Homeserve (HSV) 304.30p +2.15%Petra Diamonds Ltd.(DI) (PDL) 125.00p +2.04%Ocado Group (OCDO) 527.00p +2.03%Xaar (XAR) 1,031.00p +1.98%Greencore Group (GNC) 242.70p +1.85%Grainger (GRI) 221.70p +1.70%JD Sports Fashion (JD.) 1,651.00p +1.60%Daejan Holdings (DJAN) 4,845.00p +1.57%FTSE 250 - FallersKazakhmys (KAZ) 185.50p -4.87%Ladbrokes (LAD) 158.60p -4.86%Ferrexpo (FXPO) 171.40p -4.78%Imagination Technologies Group (IMG) 199.80p -4.36%Kenmare Resources (KMR) 18.21p -3.65%Bodycote (BOY) 685.00p -3.52%Thomas Cook Group (TCG) 180.10p -3.28%Vedanta Resources (VED) 908.50p -3.04%Laird (LRD) 306.60p -2.97%Ophir Energy (OPHR) 299.40p -2.95%BC
More News
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
21 Nov 2023 11:52

GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024

(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024.

Read more
14 Nov 2023 17:04

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook.

Read more
13 Nov 2023 09:47

GSK hails momelotinib opinion from European Medicines Agency committee

(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia.

Read more
9 Nov 2023 15:50

UK dividends calendar - next 7 days

Friday 10 November 
Bodycote PLCdividend payment date
Breedon Group PLCdividend payment date
Chesnara PLCdividend payment date
Finsbury Growth & Income Trust PLCdividend payment date
Invesco Bond Income Plus Ltddividend payment date
JPMorgan Emerging Markets Investment Trust PLCdividend payment date
Kerry Group PLCdividend payment date
Merchants Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCspecial dividend payment date
Montanaro UK Smaller Cos Investment Trust PLCdividend payment date
Senior PLCdividend payment date
Spectris PLCdividend payment date
Spirax-Sarco Engineering PLCdividend payment date
Travis Perkins PLCdividend payment date
Monday 13 November 
no events scheduled 
Tuesday 14 November 
no events scheduled 
Wednesday 15 November 
Coats Group PLCdividend payment date
Ferguson PLCdividend payment date
JP Morgan Mid Cap Investment Trust PLCdividend payment date
Strategic Equity Capital PLCdividend payment date
Thursday 16 November 
abrdn Property Income Trust Ltdex-dividend payment date
Asian Energy Impact Trust PLCex-dividend payment date
Baillie Gifford Japan Trust PLCex-dividend payment date
BlackRock Greater Europe Investment Trust PLCex-dividend payment date
Bunzl PLCex-dividend payment date
Bytes Technology Group PLCex-dividend payment date
Centrica PLCdividend payment date
Coca-Cola Europacific Partners PLCex-dividend payment date
DX Group PLCex-dividend payment date
Empiric Student Property PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
GCP Asset Backed Income Fund Ltdex-dividend payment date
GSK PLCex-dividend payment date
Hargreaves Lansdown PLCex-dividend payment date
Henderson Opportunities Trust PLCex-dividend payment date
ICG Enterprise Trust PLCex-dividend payment date
James Halstead PLCex-dividend payment date
Lancashire Holdings Ltdspecial ex-dividend payment date
Majedie Investments PLCex-dividend payment date
Marks & Spencer Group PLCex-dividend payment date
Murray Income Trust PLCex-dividend payment date
New Star Investment Trust PLCex-dividend payment date
NextEnergy Solar Fund Ltdex-dividend payment date
Octopus Renewables Infrastructure Trust PLCex-dividend payment date
Pershing Square Holdings Ltdex-dividend payment date
Personal Group Holdings PLCdividend payment date
Redrow PLCdividend payment date
Regional REIT Ltdex-dividend payment date
Schroder Oriental Income Fund Ltdex-dividend payment date
Scottish American Investment Co PLCex-dividend payment date
SCS Group PLCex-dividend payment date
Shell PLCex-dividend payment date
Supermarket Income REIT PLCdividend payment date
UK Commercial Property REIT Ltdex-dividend payment date
Unilever PLCex-dividend payment date
Wincanton PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
8 Nov 2023 09:30

LONDON BROKER RATINGS: UBS downbeat on AJ Bell and Hargreaves Lansdown

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
2 Nov 2023 10:14

LONDON BROKER RATINGS: Bank of America starts Unite Group with 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 Nov 2023 16:52

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Read more
1 Nov 2023 16:35

London close: Stocks rise ahead of US Fed policy decision

(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.

Read more
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.